225 related articles for article (PubMed ID: 35176839)
1. Castleman Disease: A Multicenter Case Series from Turkey.
Gündüz E; Kırkızlar HO; Ümit EG; Karaman Gülsaran S; Özkocaman V; Özkalemkaş F; Candar Ö; Elverdi T; Küçükyurt S; Paydaş S; Çeneli Ö; Karakuş S; Maral S; Ekinci Ö; İpek Y; Kis C; Güven ZT; Akdeniz A; Celkan T; Eroğlu Küçükdiler AH; Akgün Çağlıyan G; Özçelik Şengöz C; Karataş A; Bulduk T; Özcan A; Belen Apak FB; Canbolat A; Kartal İ; Ören H; Töret E; Özdemir GN; Bakanay Öztürk ŞM
Turk J Haematol; 2022 Jun; 39(2):130-135. PubMed ID: 35176839
[TBL] [Abstract][Full Text] [Related]
2. The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.
Borocco C; Ballot-Schmit C; Ackermann O; Aladjidi N; Delaleu J; Giacobbi-Milet V; Jannier S; Jeziorski E; Maurier F; Perel Y; Piguet C; Oksenhendler E; Koné-Paut I; Galeotti C
Orphanet J Rare Dis; 2020 Apr; 15(1):95. PubMed ID: 32303241
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
[TBL] [Abstract][Full Text] [Related]
4. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological features and survival of Castleman disease: a multicenter Turkish study.
Yildiz J; Bagci M; Sayin S; Kaya A; Yilmaz F; Ekinci O; Dal MS; Basturk A; Aydogdu I; Albayrak M; Dogan A; Erkurt MA; Korkmaz S; Ulas T; Eser B; Altuntas F
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1131-1137. PubMed ID: 35253168
[TBL] [Abstract][Full Text] [Related]
6. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
[TBL] [Abstract][Full Text] [Related]
7. Castleman disease: Experience from a single institution.
Abraham SS; Narayanan G; Thambi SM; Vasudevan JA; Joy Philip DS; Purushothaman PN; Nair SG; Nair R
Med Int (Lond); 2023; 3(6):56. PubMed ID: 37927353
[TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital.
Luo JM; Li S; Huang H; Cao J; Xu K; Bi YL; Feng RE; Huang C; Qin YZ; Xu ZJ; Xiao Y
BMC Pulm Med; 2015 Apr; 15():34. PubMed ID: 25886851
[TBL] [Abstract][Full Text] [Related]
9. Unicentric Castleman disease: A case report of an atypical presentation and successful management.
Muhammad T; Alkheder A; Mazloum A; Almooay A; Naziha L; Shaheen M
Int J Surg Case Rep; 2024 May; 118():109688. PubMed ID: 38669805
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Features and Prognosis of Patients with Castleman's Disease].
Huang XJ; Zhang XL; Wei XF; Liang XQ; Fu Y; Zhao YY; Li QF; Zhang QK; Feng YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):135-140. PubMed ID: 36765490
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
[No Abstract] [Full Text] [Related]
12. Castleman disease: A single-center case series.
Pribyl K; Vakayil V; Farooqi N; Arora N; Kreitz B; Ikramuddin S; Linden MA; Harmon J
Int J Surg Case Rep; 2021 Mar; 80():105650. PubMed ID: 33631648
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
14. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.
Zhang X; Rao H; Xu X; Li Z; Liao B; Wu H; Li M; Tong X; Li J; Cai Q
Cancer Sci; 2018 Jan; 109(1):199-206. PubMed ID: 29124835
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients.
Leite JM; Barrese TZ; Sementilli L; de Freitas LLL; do Espirito Santo KS; Delamain MT; Baiocchi OCCG; Brasil SAB; Chiattone CS
Ann Hematol; 2023 May; 102(5):1121-1129. PubMed ID: 36763110
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
Yu L; Tu M; Cortes J; Xu-Monette ZY; Miranda RN; Zhang J; Orlowski RZ; Neelapu S; Boddu PC; Akosile MA; Uldrick TS; Yarchoan R; Medeiros LJ; Li Y; Fajgenbaum DC; Young KH
Blood; 2017 Mar; 129(12):1658-1668. PubMed ID: 28100459
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment outcome of Castleman's disease: A real-world experience.
Min GJ; Jeon YW; Kim TY; Kwag DH; Lee JH; Lee JY; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
Front Oncol; 2022; 12():974770. PubMed ID: 35992883
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Bertinchamp R; Terriou L
Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.
Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
